Literature DB >> 27434867

miR-1303 promotes the proliferation of neuroblastoma cell SH-SY5Y by targeting GSK3β and SFRP1.

Zuoqing Li1, Zhe Xu1, Qigen Xie1, Wenzong Gao1, Juntao Xie1, Li Zhou2.   

Abstract

Neuroblastoma (NB) is one of the most common solid tumors in children, many microRNAs regulate progression and development of NB. Here, we found miR-1303 was upregulated in NB cells and tissues, miR-1303 overexpression promoted the proliferation of SH-SY5Y NB cell investigated by MTT assay, colony formation assay and anchorage-independent growth ability assay, while miR-1303 knockdown reduced this effect. mechanism analysis suggested glycogen synthase kinase 3 beta (GSK3β) and secreted frizzled-related protein 1 (SFRP1) were the target of miR-1303, luciferase assay revealed miR-1303 directly bound to the 3'UTR of GSK3β and SFRP1. miR-1303 increased expression of MYC and CyclinD1, and decreased the expression of p21 and p27, and further demonstrated miR-1303 promotes NB proliferation. Moreover, there was a negative correlation between miR-1303 expression and GSK3β and SFRP1 expression in NB tissues, confirming GSK3β and SFRP1 were the targets of miR-1303 in NB tissues. Collectively, our findings suggested miR-1303 promotes NB proliferation by targeting GSK3β and SFRP1, and might be a target for NB therapy.
Copyright © 2016. Published by Elsevier Masson SAS.

Entities:  

Keywords:  GSK3β; Neuroblastoma; Proliferation; SFRP1; miR-1303

Mesh:

Substances:

Year:  2016        PMID: 27434867     DOI: 10.1016/j.biopha.2016.07.010

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  13 in total

Review 1.  Targeting IGF1R pathway in cancer with microRNAs: How close are we?

Authors:  Arathy S Kumar; Suresh K Rayala; Ganesh Venkatraman
Journal:  RNA Biol       Date:  2018-02-01       Impact factor: 4.652

2.  LPP and RYR2 Gene Polymorphisms Correlate with the Risk and the Prognosis of Astrocytoma.

Authors:  Qu Chen; Yao Sun; Jiamin Wu; Zichao Xiong; Fanglin Niu; Tianbo Jin; Qiujian Zhao
Journal:  J Mol Neurosci       Date:  2019-08-23       Impact factor: 3.444

3.  Circulating MicroRNAs in Relation to Esophageal Adenocarcinoma Diagnosis and Survival.

Authors:  Jessica L Petrick; Ruth M Pfeiffer; Linda M Liao; Christian C Abnet; Xiaolin Wu; Marilie D Gammon; Thomas L Vaughan; Michael B Cook
Journal:  Dig Dis Sci       Date:  2021-01-06       Impact factor: 3.199

4.  The mutual regulatory loop between TPTEP1 and miR-1303 in leukemogenesis of acute myeloid leukemia.

Authors:  Li Li; Weidong Zhao
Journal:  Cancer Cell Int       Date:  2021-05-13       Impact factor: 5.722

Review 5.  Expression signatures and roles of microRNAs in inflammatory breast cancer.

Authors:  Yihang Qi; Xiangyu Wang; Xiangyi Kong; Jie Zhai; Yi Fang; Xiaoxiang Guan; Jing Wang
Journal:  Cancer Cell Int       Date:  2019-01-31       Impact factor: 5.722

6.  miR-1303 promotes the proliferation, migration and invasion of prostate cancer cells through regulating the Wnt/β-catenin pathway by targeting DKK3.

Authors:  Bo Liu; Weidong Zhou; Huiyang Jiang; Zhendong Xiang; Lei Wang
Journal:  Exp Ther Med       Date:  2019-10-23       Impact factor: 2.447

Review 7.  The Role of Noncoding RNAs in the Regulation of Anoikis and Anchorage-Independent Growth in Cancer.

Authors:  Han Yeoung Lee; Seung Wan Son; Sokviseth Moeng; Soo Young Choi; Jong Kook Park
Journal:  Int J Mol Sci       Date:  2021-01-10       Impact factor: 5.923

8.  MicroRNA-27a targets Sfrp1 to induce renal fibrosis in diabetic nephropathy by activating Wnt/β-Catenin signalling.

Authors:  MingJun Shi; PingPing Tian; ZhongQiang Liu; Fan Zhang; YingYing Zhang; LingLing Qu; XingMei Liu; YuanYuan Wang; XingCheng Zhou; Ying Xiao; Bing Guo
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

9.  Analysis of change in microRNA expression profiles of lung cancer A549 cells treated with Radix tetrastigma hemsleyani flavonoids.

Authors:  Peigang Liu; Xu Yang; Hongjian Zhang; Jinbao Pu; Kemin Wei
Journal:  Onco Targets Ther       Date:  2018-07-24       Impact factor: 4.147

10.  MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.

Authors:  Natarajan Aravindan; Karthikeyan Subramanian; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.